- ICH GCP
- US-Register für klinische Studien
- Klinische Studie NCT02658266
Effect of Resistance Training in Adults With Complex Congenital Heart Disease
Studienübersicht
Status
Bedingungen
Intervention / Behandlung
Detaillierte Beschreibung
The number of adults with complex congenital heart disease is increasing and today they outnumber the children with corresponding lesions. However, the longterm prognosis is still unknown and continuously changing as new therapeutic options are introduced.
Patients with complex congenital heart disease have reduced muscle function compared to healthy controls as well as patients with lesions classified as simple. Furthermore, men with congenital heart disease are more commonly underweight and less commonly overweight obese compared to the general population. In addition, men with complex lesions are shorter in comparison to controls. This indicates an altered body composition i.e. muscle mass, fat mass and bone density in this population. Moreover, impaired muscle metabolism has been reported in patients palliated with Fontan procedure.
Adult patients with complex congenital heart disease will be recruited based on defined inclusion and exclusion criteria. Muscle function, muscle strength, muscle metabolism and body composition will be evaluated before randomisation and at follow-up after twelve weeks. The patients will be randomised to twelve weeks of home based resistance training or to a control group. The randomisation ratio will be 1:1 ( intervention:control). The control group will be instructed to continue with their habitual physical activities. The resistance training protocol will be individualised based on the results of the muscle function and muscle strength tests.
The aim of this study is to investigate the effects of resistance training on muscle function, muscle strength, body composition and muscle metabolism in adults with complex congenital heart disease.
Studientyp
Einschreibung (Voraussichtlich)
Phase
- Unzutreffend
Kontakte und Standorte
Studienkontakt
- Name: Bengt Johansson, MD, PhD
- Telefonnummer: +46907852782
- E-Mail: bengt.johansson@medicin.umu.se
Studieren Sie die Kontaktsicherung
- Name: Camilla Sandberg, PhD stud
- Telefonnummer: +46907858441
- E-Mail: camilla.sandberg@medicin.umu.se
Studienorte
-
-
-
Lund, Schweden, 22185
- Abgeschlossen
- Skane University Hospital
-
Umeå, Schweden, 90185
- Rekrutierung
- University Hospital
-
Kontakt:
- Bengt Johansson, MD, PhD
- Telefonnummer: +46907852782
- E-Mail: bengt.johansson@medicin.umu.se
-
Kontakt:
- Camilla Sandberg, RPT, PhD
- Telefonnummer: +46907858441
- E-Mail: camilla.sandberg@medicin.umu.se
-
Hauptermittler:
- Bengt Johansson, MD, PhD
-
Unterermittler:
- Camilla Sandberg Sandberg, RPT, PhD
-
Uppsala, Schweden
- Rekrutierung
- University Hospital Uppsala
-
Kontakt:
- Christina Christersson, MD, Phd
-
-
Teilnahmekriterien
Zulassungskriterien
Studienberechtigtes Alter
Akzeptiert gesunde Freiwillige
Studienberechtigte Geschlechter
Beschreibung
Inclusion Criteria:
- Complex congenital heart disease ( e.g. tetralogy of Fallot, transposition of the great arteries, pulmonary atresia, patients palliated with Fontan procedure or total cavo-pulmonary connection).
- Clinically stable without significant change the last 3 months.
- Adult (> 18 years of age).
- Informed consent.
Exclusion Criteria:
- Cognitive impairment affecting the ability of independent decision making.
- Present strategy of regularly executing resistance training > 2times per week in purpose to increase muscle strength.
- Other comorbidity affecting physical activity.
- Other circumstance making participation unsuitable.
Studienplan
Wie ist die Studie aufgebaut?
Designdetails
- Hauptzweck: Behandlung
- Zuteilung: Zufällig
- Interventionsmodell: Parallele Zuordnung
- Maskierung: Single
Waffen und Interventionen
Teilnehmergruppe / Arm |
Intervention / Behandlung |
---|---|
Experimental: Resistance training
Home based resistance training 12 weeks home based resistance training 3 times per week, 10-12 reps, 2 sets
|
The participants in the intervention group will receive an individualized resistance training program.
The individual adjustments in load will will be made from the results of the muscle function and muscle strength tests.
The resistance training will be home based and performed 3 times per week 10-12 reps 2 sets 12 weeks.
Increment of load will be performed continuously according to rating of perceived exertion.
|
Kein Eingriff: Control group
No instructed exercise training.
Continue with habitual physical activity.
|
Was misst die Studie?
Primäre Ergebnismessungen
Ergebnis Maßnahme |
Zeitfenster |
---|---|
Change in muscle strength (Newton, N)
Zeitfenster: Change from baseline muscle strength at 12 weeks follow-up
|
Change from baseline muscle strength at 12 weeks follow-up
|
Sekundäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
---|---|---|
Change in muscle endurance (number of repetitions)
Zeitfenster: Change from baseline muscle endurance at 12 weeks follow-up
|
Change from baseline muscle endurance at 12 weeks follow-up
|
|
Change in total body skeletal muscle mass (kg)
Zeitfenster: Change from baseline total body skeletal muscle mass at 12 weeks follow-up
|
Using dual-energy x-ray absorptiometry (DEXA)
|
Change from baseline total body skeletal muscle mass at 12 weeks follow-up
|
Change in appendicular skeletal muscle mass (kg)
Zeitfenster: Change from baseline appendicular skeletal muscle mass at 12 weeks follow-up
|
Using dual-energy x-ray absorptiometry (DEXA)
|
Change from baseline appendicular skeletal muscle mass at 12 weeks follow-up
|
Change in body fat percentage
Zeitfenster: Change from baseline body fat percentage at 12 weeks follow-up
|
Using dual-energy x-ray absorptiometry (DEXA)
|
Change from baseline body fat percentage at 12 weeks follow-up
|
Change in bone mineral density (g/cm2)
Zeitfenster: Change from baseline bone mineral density at 12 weeks follow-up
|
Using dual-energy x-ray absorptiometry (DEXA)
|
Change from baseline bone mineral density at 12 weeks follow-up
|
Muscle metabolism
Zeitfenster: Change from baseline muscle metabolism at 12 weeks follow-up
|
near infrared spectroscopy (NIRS)
|
Change from baseline muscle metabolism at 12 weeks follow-up
|
Andere Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
---|---|---|
Compliance to study protocol
Zeitfenster: At completion of study protocol 12 weeks
|
number of training sessions
|
At completion of study protocol 12 weeks
|
Adverse events
Zeitfenster: Once a week from the date of onset of the home based exercise regimen until the followup at 12 weeks
|
Complications to resistance training
|
Once a week from the date of onset of the home based exercise regimen until the followup at 12 weeks
|
Mitarbeiter und Ermittler
Sponsor
Ermittler
- Hauptermittler: Bengt Johansson, MD, Phd, Umea University
Publikationen und hilfreiche Links
Allgemeine Veröffentlichungen
- Williams CA, Wadey C, Pieles G, Stuart G, Taylor RS, Long L. Physical activity interventions for people with congenital heart disease. Cochrane Database Syst Rev. 2020 Oct 28;10(10):CD013400. doi: 10.1002/14651858.CD013400.pub2.
- Cordina R, O'Meagher S, Gould H, Rae C, Kemp G, Pasco JA, Celermajer DS, Singh N. Skeletal muscle abnormalities and exercise capacity in adults with a Fontan circulation. Heart. 2013 Oct;99(20):1530-4. doi: 10.1136/heartjnl-2013-304249. Epub 2013 Jul 11. Erratum In: Heart. 2013 Dec;99(23):1788. Singh, Nalin [added].
- Sandberg C, Thilen U, Wadell K, Johansson B. Adults with complex congenital heart disease have impaired skeletal muscle function and reduced confidence in performing exercise training. Eur J Prev Cardiol. 2015 Dec;22(12):1523-30. doi: 10.1177/2047487314543076. Epub 2014 Jul 18.
- Kroonstrom LA, Johansson L, Zetterstrom AK, Dellborg M, Eriksson P, Cider A. Muscle function in adults with congenital heart disease. Int J Cardiol. 2014 Jan 1;170(3):358-63. doi: 10.1016/j.ijcard.2013.11.014. Epub 2013 Nov 13.
- Sandberg C, Rinnstrom D, Dellborg M, Thilen U, Sorensson P, Nielsen NE, Christersson C, Wadell K, Johansson B. Height, weight and body mass index in adults with congenital heart disease. Int J Cardiol. 2015;187:219-26. doi: 10.1016/j.ijcard.2015.03.153. Epub 2015 Mar 18.
Studienaufzeichnungsdaten
Haupttermine studieren
Studienbeginn
Primärer Abschluss (Voraussichtlich)
Studienabschluss (Voraussichtlich)
Studienanmeldedaten
Zuerst eingereicht
Zuerst eingereicht, das die QC-Kriterien erfüllt hat
Zuerst gepostet (Schätzen)
Studienaufzeichnungsaktualisierungen
Letztes Update gepostet (Tatsächlich)
Letztes eingereichtes Update, das die QC-Kriterien erfüllt
Zuletzt verifiziert
Mehr Informationen
Begriffe im Zusammenhang mit dieser Studie
Schlüsselwörter
Zusätzliche relevante MeSH-Bedingungen
Andere Studien-ID-Nummern
- GUCHUmU02
Plan für individuelle Teilnehmerdaten (IPD)
Planen Sie, individuelle Teilnehmerdaten (IPD) zu teilen?
Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .
Klinische Studien zur Angeborener Herzfehler
-
Cairo UniversityNoch keine RekrutierungSocket Preservation, Alveolar Ridge Defect, Alveolar Ridge Preservation
-
Region SkaneAnmeldung auf EinladungHerzinsuffizienz New York Heart Association (NYHA) Klasse II | Herzinsuffizienz New York Heart Association (NYHA) Klasse IIISchweden
-
Medical University of BialystokInstitute of Cardiology, Warsaw, Poland; Medical University of Lodz; Poznan University... und andere MitarbeiterNoch keine RekrutierungHerzinsuffizienz, systolisch | Herzinsuffizienz mit reduzierter Ejektionsfraktion | Herzinsuffizienz New York Heart Association Klasse IV | Herzinsuffizienz New York Heart Association Klasse IIIPolen
-
University of WashingtonAmerican Heart AssociationAbgeschlossenHerzinsuffizienz, kongestive | Mitochondriale Veränderung | Herzinsuffizienz New York Heart Association Klasse IVVereinigte Staaten
-
Abbott Medical DevicesThoratec CorporationAbgeschlossenDriveline Heart-assisted Device Related InfectionVereinigte Staaten
-
Medical University of South CarolinaAmerican Heart AssociationAbgeschlossenSingle Ventricle Heart Disease nach Fontan-OperationVereinigte Staaten
-
Mezzion Pharma Co. LtdNational Heart, Lung, and Blood Institute (NHLBI); Pediatric Heart NetworkAbgeschlossenSingle Ventricle Heart Disease nach Fontan-OperationVereinigte Staaten, Kanada
-
University Hospital, GasthuisbergUnbekanntTransient Left Ventricular Ballooning SyndromeBelgien
-
NYU Langone HealthRekrutierungTako-Tsubo-Kardiomyopathie | Takotsubo-Kardiomyopathie | Broken-Heart-SyndromVereinigte Staaten
-
French Cardiology SocietyAbgeschlossen
Klinische Studien zur Home based resistance training
-
University of MiamiUnited States Department of DefenseAnmeldung auf Einladung
-
University of ZurichRadboud University Medical Center; Johannes Gutenberg University Mainz; Leuven...Abgeschlossen
-
Memorial Sloan Kettering Cancer CenterAktiv, nicht rekrutierendBrustkrebsVereinigte Staaten
-
King Edward Medical UniversityAbgeschlossenSchulpsychiatrische Ausbildung von LehrernPakistan
-
Necmettin Erbakan UniversityAbgeschlossenAkute Exazerbation von COPDTruthahn
-
Universidad Pontificia de SalamancaMinisterio de Ciencia e Innovación, SpainRekrutierungEntzündungsreaktion | Wohlbefinden | Psychische Gesundheit | Achtsamkeit | Herz-Kreislauf-Gesundheit | SelbstmitgefühlSpanien
-
Singapore General HospitalDuke-NUS Graduate Medical SchoolAbgeschlossenLeichte kognitive EinschränkungSingapur
-
Oregon Research InstituteUniversity of Oregon; Radboud University Medical Center; University of Exeter; Flinders...AbgeschlossenFettleibigkeit | Ernährungs- und Essstörungen | HyperphagieVereinigte Staaten
-
McGill UniversityAbgeschlossenChirurgische AusbildungKanada
-
Dartmouth-Hitchcock Medical CenterCenters for Disease Control and PreventionAbgeschlossen